EdgarLookup

USCB FINANCIAL HOLDINGS, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that USCB FINANCIAL HOLDINGS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0.9%
Return on Assets
Net income ÷ assets
11.85x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $26.10M Mar 13, 2026
FY2025 Dec 31, 2024 $24.67M Mar 13, 2026
FY2024 Dec 31, 2023 $16.55M Mar 14, 2025
FY2023 Dec 31, 2022 $20.14M Mar 22, 2024
FY2022 Dec 31, 2021 $21.08M Mar 28, 2023
FY2021 Dec 31, 2020 $10.82M Mar 24, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $42.81M Mar 13, 2026
FY2025 Dec 31, 2024 $34.84M Mar 13, 2026
FY2024 Dec 31, 2023 $22.55M Mar 14, 2025
FY2023 Dec 31, 2022 $29.54M Mar 22, 2024
FY2022 Dec 31, 2021 $22.05M Mar 28, 2023
FY2021 Dec 31, 2020 $13.10M Mar 24, 2022

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $303.0K Mar 13, 2026
FY2025 Dec 31, 2024 $314.0K Mar 13, 2026
FY2024 Dec 31, 2023 $163.0K Mar 14, 2025
FY2023 Dec 31, 2022 $673.0K Mar 22, 2024
FY2022 Dec 31, 2021 $633.0K Mar 28, 2023
FY2021 Dec 31, 2020 $347.0K Mar 24, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.79B Mar 13, 2026
FY2025 Dec 31, 2024 $2.58B Mar 13, 2026
FY2024 Dec 31, 2023 $2.34B Mar 14, 2025
FY2023 Dec 31, 2022 $2.09B Mar 22, 2024
FY2022 Dec 31, 2021 $1.85B Mar 28, 2023
FY2021 Dec 31, 2020 $1.50B Mar 24, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.57B Mar 13, 2026
FY2025 Dec 31, 2024 $2.37B Mar 13, 2026
FY2024 Dec 31, 2023 $2.15B Mar 14, 2025
FY2023 Dec 31, 2022 $1.90B Mar 22, 2024
FY2022 Dec 31, 2021 $1.65B Mar 28, 2023
FY2021 Dec 31, 2020 $1.33B Mar 24, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $217.18M Mar 13, 2026
FY2025 Dec 31, 2024 $215.39M Mar 13, 2026
FY2025 Dec 31, 2023 $191.97M Mar 13, 2026
FY2024 Dec 31, 2022 $182.43M Mar 14, 2025
FY2023 Dec 31, 2021 $203.90M Mar 22, 2024
FY2022 Dec 31, 2020 $171.00M Mar 28, 2023
FY2021 Dec 31, 2019 $160.28M Mar 24, 2022

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($49.54M) Mar 13, 2026
FY2025 Dec 31, 2024 ($67.81M) Mar 13, 2026
FY2024 Dec 31, 2023 ($88.55M) Mar 14, 2025
FY2023 Dec 31, 2022 ($104.10M) Mar 22, 2024
FY2022 Dec 31, 2021 ($124.25M) Mar 28, 2023
FY2021 Dec 31, 2020 ($53.62M) Mar 24, 2022

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $38.48M Mar 13, 2026
FY2025 Dec 31, 2024 $77.04M Mar 13, 2026
FY2024 Dec 31, 2023 $41.06M Mar 14, 2025
FY2023 Dec 31, 2022 $54.17M Mar 22, 2024
FY2022 Dec 31, 2021 $46.23M Mar 28, 2023
FY2021 Dec 31, 2020 $47.73M Mar 24, 2022

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Mar 13, 2026
FY2025 Dec 31, 2024 1 Mar 13, 2026

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Mar 13, 2026
FY2025 Dec 31, 2024 1 Mar 13, 2026